Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3129 results

Sort By:

Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers

Study ID: NCT07070804
Start Date: 2026-09-01
End Date: 2028-08-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

None-placebo

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Study ID: NCT07293247
Start Date: 2026-03-14
End Date: 2032-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

164

Intervention / Treatment

Chemotherapy

Immunotherapy

Intensity-Modulated Radiation Therapy

Computed Tomography

Magnetic Resonance Imaging

Fludeoxyglucose F-18

Biospecimen Collection

Sponsor

Alliance for Clinical Trials in Oncology

Source: clinicaltrials.gov

Share:
Add to list

Real-world Trial of Individualized Precision Oncology

Study ID: NCT07346209
Start Date: 2026-03
End Date: 2031-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

280

Intervention / Treatment

Molecularly matched therapy

Standard of care

Sponsor

University of California, San Diego

Source: clinicaltrials.gov

Share:
Add to list

Deep Brain Stimulation for Spinocerebellar Ataxia

Study ID: NCT07288437
Start Date: 2026-03
End Date: 2031-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5

Intervention / Treatment

Deep Brain Stimulation (DBS)

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

Study ID: NCT07332507
Start Date: 2026-02-26
End Date: 2027-02-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Positron Emission Tomography

Teclistamab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Dysfunctional Renin-Angiotensin System in Septic Shock

Study ID: NCT06746753
Start Date: 2026-03
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase4

No. of Participants

78

Intervention / Treatment

Angiotensin II

Norepinephrine

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Study ID: NCT07321912
Start Date: 2026-04-01
End Date: 2036-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

406

Intervention / Treatment

Eflornithine

Topotecan

Cyclophosphamide

Vincristine

Doxorubicin

Ifosfamide

Etoposide

Cisplatin

Methotrexate

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

AVF-MONITOR POC Proof-of-concept Study

Study ID: NCT07318025
Start Date: 2026-03
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

6

Intervention / Treatment

AVF MONITOR

Sponsor

Mario Negri Institute for Pharmacological Research

Source: clinicaltrials.gov

Share:
Add to list

STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis

Study ID: NCT07332325
Start Date: 2026-04
End Date: 2029-09
Study Type

Interventional

Study Phase

Phase3

No. of Participants

344

Intervention / Treatment

Hydrocortisone administration

Expanded antimicrobial therapy

Sponsor

University of Virginia

Source: clinicaltrials.gov

Share:
Add to list

Palm Stimulator Use During Peripheral Venous Catheterization

Study ID: NCT07387497
Start Date: 2026-02-20
End Date: 2026-07-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Palm Stimulator Group

Sponsor

Zeliha CENGİZ

Source: clinicaltrials.gov

Share:
Add to list